New glioblastoma vaccine: safe and immunogenic in phase 1.
Eva M
EM
Riedmann
D019496:Cancer Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology*; D017321:Clinical Trials, Phase I as Topic; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D016896:Treatment Outcome
D019496:Cancer Vaccines